DE60235544D1 - Stabile pulververabreichungsform zur inhalation - Google Patents

Stabile pulververabreichungsform zur inhalation

Info

Publication number
DE60235544D1
DE60235544D1 DE60235544T DE60235544T DE60235544D1 DE 60235544 D1 DE60235544 D1 DE 60235544D1 DE 60235544 T DE60235544 T DE 60235544T DE 60235544 T DE60235544 T DE 60235544T DE 60235544 D1 DE60235544 D1 DE 60235544D1
Authority
DE
Germany
Prior art keywords
inhalation
stable powder
powder administration
administration
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60235544T
Other languages
German (de)
English (en)
Inventor
Frank M Etzler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharmaceuticals Inc
Original Assignee
Boehringer Ingelheim Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharmaceuticals Inc filed Critical Boehringer Ingelheim Pharmaceuticals Inc
Application granted granted Critical
Publication of DE60235544D1 publication Critical patent/DE60235544D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/29Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE60235544T 2001-06-20 2002-06-11 Stabile pulververabreichungsform zur inhalation Expired - Lifetime DE60235544D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/885,349 US6482429B1 (en) 2001-06-20 2001-06-20 Stable powder inhalation dosage formulation
PCT/US2002/018406 WO2003000240A2 (en) 2001-06-20 2002-06-11 Stable powder inhalation dosage formulation

Publications (1)

Publication Number Publication Date
DE60235544D1 true DE60235544D1 (de) 2010-04-15

Family

ID=25386707

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60235544T Expired - Lifetime DE60235544D1 (de) 2001-06-20 2002-06-11 Stabile pulververabreichungsform zur inhalation

Country Status (9)

Country Link
US (1) US6482429B1 (enExample)
EP (1) EP1401409B1 (enExample)
JP (1) JP4348179B2 (enExample)
AT (1) ATE459346T1 (enExample)
CA (1) CA2446221C (enExample)
DE (1) DE60235544D1 (enExample)
ES (1) ES2339751T3 (enExample)
MX (1) MXPA03011517A (enExample)
WO (1) WO2003000240A2 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9408499D0 (en) 1994-04-28 1994-06-22 Edwin Shirley Trucking Limited A releasable joint for joining two construction elements of a transportable stage assembly
BR0107304A (pt) * 2000-10-12 2002-08-13 Boehringer Ingelheim Pharma Pó para inalação contendo tiotrópio
US6620438B2 (en) * 2001-03-08 2003-09-16 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics and NK1-receptor antagonists
US7776315B2 (en) * 2000-10-31 2010-08-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and additional active ingredients
US20020193392A1 (en) * 2000-11-13 2002-12-19 Christel Schmelzer Pharmaceutical compositions based on tiotropium salts of salts of salmeterol
US20100310477A1 (en) * 2000-11-28 2010-12-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg. Pharmaceutical compositions based on anticholingerics and additional active ingredients
US20030070679A1 (en) * 2001-06-01 2003-04-17 Boehringer Ingelheim Pharma Kg Capsules containing inhalable tiotropium
DE10141377A1 (de) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Aufstreuverfahren zur Herstellung von Pulverformulierungen
US6919325B2 (en) 2001-09-14 2005-07-19 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts
US7309707B2 (en) * 2002-03-20 2007-12-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
BR0308984A (pt) * 2002-04-04 2005-02-09 Boehringer Ingelheim Pharma Formulações em pó adequadas para inalação
US7763280B2 (en) * 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
AU2004291542A1 (en) * 2003-11-18 2005-06-02 Yansong Shan Healthy pleasurable inhalation device
CA2550811C (en) * 2003-12-24 2012-05-01 Jane Hirsh Temperature-stable formulations, and methods of development thereof
JP5001847B2 (ja) * 2005-09-27 2012-08-15 旭化成ケミカルズ株式会社 セロオリゴ糖含有組成物
US20080035143A1 (en) * 2006-08-14 2008-02-14 Sievers Robert E Human-powered dry powder inhaler and dry powder inhaler compositions
TR201007250A2 (tr) * 2010-09-01 2012-03-21 Bi̇lgi̇ç Mahmut Selobioz içeren formülasyon.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302777D0 (sv) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
US5846516A (en) * 1992-06-03 1998-12-08 Alliance Pharmaceutial Corp. Perfluoroalkylated amphiphilic phosphorus compounds: preparation and biomedical applications
SE9203743D0 (sv) * 1992-12-11 1992-12-11 Astra Ab Efficient use
US5612053A (en) * 1995-04-07 1997-03-18 Edward Mendell Co., Inc. Controlled release insufflation carrier for medicaments
WO2002015880A2 (en) * 2000-08-25 2002-02-28 Merck Patent Gmbh Powdered mannitol and mannitol-containing compositions

Also Published As

Publication number Publication date
CA2446221C (en) 2011-04-12
ATE459346T1 (de) 2010-03-15
MXPA03011517A (es) 2004-03-18
US6482429B1 (en) 2002-11-19
JP2004534813A (ja) 2004-11-18
WO2003000240A2 (en) 2003-01-03
JP4348179B2 (ja) 2009-10-21
CA2446221A1 (en) 2003-01-03
ES2339751T3 (es) 2010-05-25
EP1401409B1 (en) 2010-03-03
WO2003000240A3 (en) 2003-03-06
EP1401409A2 (en) 2004-03-31

Similar Documents

Publication Publication Date Title
DE60235544D1 (de) Stabile pulververabreichungsform zur inhalation
WO2003026559A3 (en) Nasal nebulizer
MXPA04003465A (es) Tratamiento de enfermedades hiperproliferativas, con el uso de analogos activos de la vitamina d.
MXPA04003668A (es) Inhibidores de fosfodiesteresa de tipo 4 y usos de los mismos.
MXPA04004173A (es) Formas orales de liberacion controlada utiles para la reduccion o prevencion de la ansiedad hacia la nicotina.
WO2002069945A3 (de) Neue arzneimittelkompositionen auf der basis von anticholinergika und pde-iv-inhibitoren
ATE420762T1 (de) Systeme, verfahren und geräte zur herstellung von dosierungsformen
DE60308997D1 (de) Formulierungen zur inhalation
ATE556704T1 (de) Pulverinhalator-formulierungen
MXPA03010134A (es) Derivados de ciclohexan-1-4-diamina sustituidos.
WO2004066912A3 (en) Anti-inflammatory compositions and uses thereof
CA96911S (en) Cartridge for an air freshener
MXPA03007140A (es) Derivados de carbolina.
WO2004100926A3 (en) Delivery of agents using hydrolyzable leaving groups
BR0302834A (pt) Anel sincronizador de divisões múltiplas de um conjunto sincronizador
MXPA03005980A (es) Composiciones para administracion nasal de insulina.
WO2004056347A3 (en) Pharmaceutical compositions comprising insulin and legends of insulin hexamer
PT1485154E (pt) Dispositivo de inalação de pó
PT1435991E (pt) Utilização de aplidina para o tratamento de cancro pancreático
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.
WO2002024181A3 (en) The use of melatonin for induction of general anesthesia
WO2004062640A3 (de) Kapsel zur aufnahme eines inhalativ applizierbaren wirkstoffs
AU2003281257A1 (en) A novel use of rapamycin and structural analogues thereof
MY137953A (en) New association of an anti-atherothrombotic agent and an anti-platelet-aggregation agent
WO2002066025A3 (de) Wirkstoffkombination aus dem racemat des tramadols und dem (+)-o-desmethyltramadol

Legal Events

Date Code Title Description
8364 No opposition during term of opposition